Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study. (Chen A, Krenitsky A, Perry SS, Tan KW, Swick BL, Anderson KR, Barry KK, Berman K, Carlberg VM, Coughlin CC, Craddock M, Fadzeyeva H, Ferringer T, Gerami P, Grichnik JM, Hawryluk EB, Hogeling M, Humphrey SR, Harview CL, Berrebi KG) J Am Acad Dermatol 2026 May 08 PMID: 42107785 PMCID: PMC13277796 SCOPUS ID: 2-s2.0-105040068832 05/11/2026
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature. (Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL) Support Care Cancer 2024 Aug 23;32(9):610 PMID: 39174797 SCOPUS ID: 2-s2.0-85201799418 08/23/2024 8 Citations
Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins. (Tanaka R, Mrachek K, Arocho-Quinones E, Carlberg VM, Smith C, Kurzrock R, Deshmukh T) JCO Precis Oncol 2024 May;8:e2400055 PMID: 38781546 SCOPUS ID: 2-s2.0-85200505701 05/23/2024